Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction.

Importance Short-term outcomes after acute myocardial infarction (AMI) have improved, but little is known about longer-term outcomes. Objective To evaluate trends in 10-year all-cause mortality and hospitalization for recurrent AMI by demographic subgroups and examine the association between recurrence and mortality. Design, Setting, and Participants Medicare fee-for-service beneficiaries who survived after AMI from 1995 to 2019. Subgroups were defined by age, sex, race, dual Medicare-Medicaid-eligible status, and residence in health priority areas (geographic areas with persistently high adjusted mortality and hospitalization rates). Data were analyzed from October 2020 to February 2022. Exposure Medicare fee-for-service beneficiaries who survived an AMI. Main Outcomes and Measures Ten-year all-cause mortality and hospitalization for recurrent AMI, beginning 30 days from the index AMI admission. Results Of an included 3 982 266 AMI survivors, 1 952 450 (49.0%) were female, and the mean (SD) age was 78.0 (7.4) years. Ten-year mortality and recurrent AMI rates were 72.7% (95% CI, 72.6-72.7) and 27.1% (95% CI, 27.0-27.2), respectively. Adjusted annual reductions were 1.5% (95% CI, 1.4-1.5) for mortality and 2.7% (95% CI, 2.6-2.7) for recurrence. In subgroup analyses balancing patient characteristics, hazard ratios (HRs) for mortality and recurrence were 1.13 (95% CI, 1.12-1.13) and 1.07 (95% CI, 1.06-1.07), respectively, for men vs women; 1.05 (95% CI, 1.05-1.06) and 1.08 (95% CI, 1.07-1.09) for Black vs White patients; 0.96 (95% CI, 0.95-0.96) and 1.00 (95% CI, 1.00-1.01) for other race (including American Indian and Alaska Native, Asian, Hispanic, other race or ethnicity, and unreported) vs White patients; 1.24 (95% CI, 1.24-1.24) and 1.21 (95% CI, 1.20-1.21) for dual Medicare-Medicaid-eligible vs non-dual Medicare-Medicaid-eligible patients; and 1.06 (95% CI, 1.06-1.07) and 1.00 (95% CI, 1.00-1.01) for patients in health priority areas vs other areas. For patients hospitalized in 2007 to 2009, the last 3 years for which full 10-year follow-up data were available, 10-year mortality risk was 13.9% lower than for those hospitalized in 1995 to 1997 (adjusted HR, 0.86; 95% CI, 0.85-0.87) and 10-year recurrence risk was 22.5% lower (adjusted HR, 0.77; 95% CI, 0.76-0.78). Mortality within 10 years after the initial AMI was higher for patients with a recurrent AMI (80.6%; 95% CI, 80.5-80.7) vs those without recurrence (72.4%; 95% CI, 72.3-72.5). Conclusions and Relevance In this study, 10-year mortality and hospitalization for recurrence rates improved over the last decades for patients who survived the acute period of AMI. There were marked differences in outcomes and temporal trends across demographic subgroups, emphasizing the urgent need for prioritization of efforts to reduce inequities in long-term outcomes.

[1]  T. Murohara,et al.  Ten-year Mortality in Patients with ST-Elevation Myocardial Infarction. , 2021, The American journal of cardiology.

[2]  S. Hohmann,et al.  Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States , 2020, Journal of Stroke and Cerebrovascular Diseases.

[3]  F. Dominici,et al.  Mortality and Hospitalizations for Dually Enrolled and Nondually Enrolled Medicare Beneficiaries Aged 65 Years or Older, 2004 to 2017. , 2020, JAMA.

[4]  M. Terris,et al.  Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. , 2019, JAMA oncology.

[5]  A. Jha,et al.  Assessment of Strategies for Managing Expansion of Diagnosis Coding Using Risk-Adjustment Methods for Medicare Data. , 2019, JAMA internal medicine.

[6]  Nishant R. Shah,et al.  Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction , 2019, Circulation. Cardiovascular quality and outcomes.

[7]  S. Normand,et al.  Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States , 2019, JAMA network open.

[8]  John Fuller,et al.  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials , 2019, The Lancet.

[9]  S. Normand,et al.  Geographical Health Priority Areas For Older Americans. , 2018, Health affairs.

[10]  B. Lau,et al.  Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada , 2017, AIDS patient care and STDs.

[11]  S. Johansson,et al.  Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review , 2017, BMC Cardiovascular Disorders.

[12]  S. Nuti,et al.  Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013. , 2015, JAMA.

[13]  K. Alexander,et al.  The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR®. , 2014, American heart journal.

[14]  H. Krumholz,et al.  National Trends in Recurrent AMI Hospitalizations 1 Year After Acute Myocardial Infarction in Medicare Beneficiaries: 1999–2010 , 2014, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[15]  S. Normand,et al.  Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011 , 2014, Circulation.

[16]  Neel M. Butala,et al.  Sex Differences in Long-Term Mortality After Myocardial Infarction: A Systematic Review , 2014, Circulation.

[17]  H. Barron,et al.  Transforming quality of care and improving outcomes after acute MI: lessons from the National Registry of Myocardial Infarction. , 2012, JAMA.

[18]  M. Goldacre,et al.  Long-Term Survival and Recurrence After Acute Myocardial Infarction in England, 2004 to 2010 , 2012, Circulation. Cardiovascular quality and outcomes.

[19]  Christopher D. Barr,et al.  Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats? , 2012, Circulation. Cardiovascular quality and outcomes.

[20]  Christopher P Cannon,et al.  A Call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): A National Effort to Promote Timely Clinical Feedback and Support Continuous Quality Improvement for Acute Myocardial Infarction , 2009, Circulation. Cardiovascular quality and outcomes.

[21]  S. Normand,et al.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.

[22]  A. Ryan,et al.  The Relationship between Medicare's Process of Care Quality Measures and Mortality , 2009, Inquiry : a journal of medical care organization, provision and financing.

[23]  J. Reitsma,et al.  Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus , 2007, European Journal of Epidemiology.

[24]  Harlan M Krumholz,et al.  Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. , 2006, JAMA.

[25]  Harlan M Krumholz,et al.  ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society , 2005, Circulation.

[26]  Stephen R Cole,et al.  Adjusted survival curves with inverse probability weights , 2004, Comput. Methods Programs Biomed..

[27]  S. Jencks,et al.  Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. , 2003, JAMA.

[28]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[29]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[30]  H. Krumholz,et al.  Aspirin for Secondary Prevention after Acute Myocardial Infarction in the Elderly: Prescribed Use and Outcomes , 1996, Annals of Internal Medicine.